Presented at EAU on March 23, 2009 The drug Denosumab has shown itself both easy to tolerate by patients as well highly able to increases bone mineral density (BMD) when compared with placebo in men with nonmetastatic prostate cancer receiving androgen deprivation therapy (ADT). The results of this multi-centre, randomized, double-blind, placebo-controlled, phase 3 study [...]
One of the unsettled debates in our advanced prostate cancer world surrounds the issue of continuous vs. intermittent hormone therapy (IHT). Traditionally, hormone therapy was continuous, or once you started you never stopped the treatment. As many of us know, hormone therapy is notorious for damaging the quality of life. Hot flashes, loss of libido, [...]
That is the big question I am dealing with this week. I have been so pleased with my recent success with lowering my PSA, but the last test has reversed the trend. My PSA has shown a drastic rise. It went from just under .60 to almost 2.0 within a two week period! As we [...]
If I hear it one more time I am going to tear my hair out. What do you mean that prostate cancer is not fatal, prostate cancer is the second largest cancer killer after only lung cancer. TARA PARKER-POPE wrote in yesterdays New York Times a health article, "Screen or Not? What Those Prostate Studies [...]
The FDA has issued an emergency warning that certain adhesive patches (transdermal patches) that deliver medication through the skin have been found to be a risk to patients safety while they undergo a magnetic resonance imaging (MRI). If these problem patches are affixed to the skin while actually undergoing the scan they can cause skin [...]